These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3521856

  • 1. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I, Cornell RC, Penneys NS, Zaias N.
    Clin Ther; 1986; 8(3):275-82. PubMed ID: 3521856
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
    Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
    [Abstract] [Full Text] [Related]

  • 3. Treatment of refractory psoriasis with fluocinonide gel.
    Willoughby CB, Cook WR.
    Cutis; 1977 Jul; 20(1):144-5. PubMed ID: 884957
    [Abstract] [Full Text] [Related]

  • 4. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis.
    Ellis CN, Katz HI, Rex IH, Shavin JS, Van Scott EJ, VanderPloeg D.
    Clin Ther; 1989 Jul; 11(6):768-74. PubMed ID: 2692821
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
    Kuokkanen K.
    Curr Med Res Opin; 1989 Jul; 4(10):703-5. PubMed ID: 800971
    [Abstract] [Full Text] [Related]

  • 6. Preliminary clinical evaluation of a new topical corticosteroid, halopredone acetate, as compared to fluocinonide.
    Rampini E, Rastelli A, Divano C.
    Arzneimittelforschung; 1977 Jul; 27(12):2396-9. PubMed ID: 341903
    [Abstract] [Full Text] [Related]

  • 7. [Treatment with topical corticosteroids in severe or resistant dermatoses].
    Nolting S.
    Derm Beruf Umwelt; 1985 Jul; 33(4):140-4. PubMed ID: 2931266
    [Abstract] [Full Text] [Related]

  • 8. Fluocinolone acetonide topical oil for scalp psoriasis.
    Pauporte M, Maibach H, Lowe N, Pugliese M, Friedman DJ, Mendelsohn H, Cargill I, Ramirez R.
    J Dermatolog Treat; 2004 Dec; 15(6):360-4. PubMed ID: 15764047
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 12. [Comparative study of 2 topical steroids preparations: desoximetasone and betamethasone dipropionate].
    Magnin PH, Torchinsky O, Baabour SD.
    Med Cutan Ibero Lat Am; 1978 Jul; 6(3-4):203-8. PubMed ID: 398919
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eszematous dermatoses.
    Sudilovsky A, Clewe TH.
    J Clin Pharmacol; 1975 Jul; 15(11-12):779-84. PubMed ID: 1104668
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.